Metsera Inc. (NASDAQ:MTSR) Given Average Rating of "Hold" by Analysts

Key Points

• Metsera Inc. (NASDAQ:MTSR) has received an average rating of "Hold" from eight brokerages, with one sell, three hold, and four buy ratings among analysts.
• Analysts have set an average twelve-month target price of $55.75 for Metsera's shares, reflecting varying perspectives on future performance.
• Several institutional investors increased their holdings in Metsera during the first quarter, notably with Alphabet Inc. investing approximately $135 million in the company.

Shares of Metsera Inc. (NASDAQ:MTSR - Get Free Report) have received an average rating of "Hold" from the eight brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $55.75.

Several brokerages recently commented on MTSR. Bank of America lifted their target price on shares of Metsera from $45.00 to $50.00 and gave the stock a "buy" rating in a report on Thursday, August 28th. Cantor Fitzgerald reiterated an "overweight" rating on shares of Metsera in a report on Wednesday, September 3rd. Leerink Partnrs downgraded shares of Metsera from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 24th. Leerink Partners restated a "market perform" rating and set a $57.00 price objective (down previously from $77.00) on shares of Metsera in a report on Wednesday, September 24th. Finally, Wall Street Zen upgraded shares of Metsera from a "sell" rating to a "hold" rating in a report on Wednesday, October 1st.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in MTSR. Bank of New York Mellon Corp bought a new position in shares of Metsera during the 1st quarter worth about $884,000. New York State Common Retirement Fund bought a new position in shares of Metsera during the 1st quarter worth about $131,000. Alphabet Inc. bought a new position in shares of Metsera during the 1st quarter worth about $135,059,000. Massachusetts Financial Services Co. MA bought a new position in shares of Metsera during the 1st quarter worth about $13,111,000. Finally, Jennison Associates LLC bought a new position in shares of Metsera during the 1st quarter worth about $9,679,000.

Metsera Stock Up 0.2%

MTSR stock opened at $52.99 on Friday. Metsera has a 1 year low of $12.30 and a 1 year high of $54.47. The company has a fifty day simple moving average of $41.37 and a 200 day simple moving average of $32.68.

Metsera (NASDAQ:MTSR - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported ($0.66) earnings per share (EPS) for the quarter.

Metsera Company Profile

Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.